Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001513162-20-000012
Filing Date
2020-01-10
Accepted
2020-01-10 17:16:30
Documents
6
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A form10k_a.htm 10-K/A 1630528
2 EXHIBIT 23.1 exhibit23_1.htm EX-23.1 2357
3 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 25114
4 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 23524
5 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 9122
6 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 9843
  Complete submission text file 0001513162-20-000012.txt   1701669
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 001-37492 | Film No.: 20521974
SIC: 8071 Services-Medical Laboratories